Black patients with memory impairment are known to experience lower rates of amyloid positivity than non‐Hispanic White patients;38 thus, non–amyloid‐related biomarkers, such as NfL, have been proposed as effective tools for predicting future cognitive decline in Black participants.39 This evidence concerns the gene NEFL and memory impairment.